The transition from genomics to phenomics in personalized population health

JT Yurkovich, SJ Evans, N Rappaport, JL Boore… - Nature Reviews …, 2024 - nature.com
Modern health care faces several serious challenges, including an ageing population and
its inherent burden of chronic diseases, rising costs and marginal quality metrics. By …

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

SS Martin, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Current insights and emerging trends in early-onset type 2 diabetes

S Misra, C Ke, S Srinivasan, A Goyal… - The Lancet Diabetes & …, 2023 - thelancet.com
Type 2 diabetes diagnosed in childhood or early adulthood is termed early-onset type 2
diabetes. Cases of early-onset type 2 diabetes are increasing rapidly globally, alongside …

Ethnic differences between Asians and non-Asians in clustering-based phenotype classification of adult-onset diabetes mellitus: a systematic narrative review

JS Varghese, KMV Narayan - Primary care diabetes, 2022 - Elsevier
Several international studies have stratified people with diabetes into phenotypical clusters.
However, there has not been a systematic examination of the variation in these clusters …

[HTML][HTML] Advancing the communication of genetic risk for cardiometabolic diseases: a critical interpretive synthesis

JH Law, N Sultan, S Finer, N Fudge - BMC medicine, 2023 - Springer
Background Genetics play an important role in risk for cardiometabolic diseases—including
type 2 diabetes, cardiovascular disease and obesity. Existing research has explored the …

[HTML][HTML] Integrating common risk factors with polygenic scores improves the prediction of type 2 diabetes

Y Timasheva, Z Balkhiyarova, D Avzaletdinova… - International Journal of …, 2023 - mdpi.com
We tested associations between 13 established genetic variants and type 2 diabetes (T2D)
in 1371 study participants from the Volga-Ural region of the Eurasian continent, and …

Assessing the prediction of type 2 diabetes risk using polygenic and clinical risk scores in South Asian study populations

M Rout, GS Wander, S Ralhan… - Therapeutic …, 2023 - journals.sagepub.com
Background: Genome-wide polygenic risk scores (PRS) have shown high specificity and
sensitivity in predicting type 2 diabetes (T2D) risk in Europeans. However, the PRS-driven …

[HTML][HTML] Recent advances in polygenic scores: translation, equitability, methods and FAIR tools

R Xiang, M Kelemen, Y Xu, LW Harris, H Parkinson… - Genome Medicine, 2024 - Springer
Polygenic scores (PGS) can be used for risk stratification by quantifying individuals' genetic
predisposition to disease, and many potentially clinically useful applications have been …

The Prospect of Genomic, Transcriptomic, Epigenetic and Metabolomic Biomarkers for The Personalized Prevention of Type 2 Diabetes and Cardiovascular Diseases

A Zeljkovic, M Mihajlovic, S Vujcic… - Current Vascular …, 2023 - ingentaconnect.com
Cardiometabolic diseases, such as type 2 diabetes mellitus (DM) and cardiovascular
disease (CVD), are a great health concern. The strategies aimed to increase awareness and …

[HTML][HTML] A Strategic Research Framework for Defeating Diabetes in India: A 21st-Century Agenda

KMV Narayan, JS Varghese, YS Beyh… - Journal of the Indian …, 2023 - Springer
Indian people are at high risk for type 2 diabetes (T2DM) even at younger ages and lower
body weights. Already 74 million people in India have the disease, and the proportion of …